Two case reports of transcatheter valve-in-valve implantation of Sapien 3 and MyVal in degenerated biological tricuspid prosthesis valves

European Heart Journal - Case Reports

23 March 2022
Organised by: Logo
ESC Journals

Abstract

AbstractBackground

Patients with severe tricuspid valve stenosis or dysfunction following degeneration of biological valve prosthesis in tricuspid position are complex, have substantial comorbidity, and very high surgical risk.

Case summary

We report two cases with transcatheter tricuspid valve-in-valve implantation in patients with degenerated tricuspid bioprosthesis with transfemoral and transjugular access with Sapien 3 valve and MyVal, respectively.

Discussion

In patients with high surgical risk, transcatheter tricuspid valve implantation is a good alternative. Careful consideration of optimal access site, device size, and delivery system is paramount. This case report demonstrates technically feasible and safe transcatheter valve-in-valve implantantion in tricuspid position and highlights the importance of meticulous procedure planning.

Contributors

Rebekka Vibjerg Jensen
Rebekka Vibjerg Jensen

Author

Aarhus University Hospital Aarhus , Denmark

Jesper Khedri Jensen
Jesper Khedri Jensen

Author

Odense University Hospital Odense , Denmark

Evald Høj Christiansen
Evald Høj Christiansen

Author

Aarhus University Hospital Aarhus , Denmark